VivoSeq
Other

Lipid Emulsion

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Lipid Emulsion is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

20/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

10

clinical trials

Completed8 · 80%
Terminated2 · 20%

Clinical Trials

Trial Activity

10 trials

The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns
Completed·TThe University of Texas Health Science Center, Houston·Phase 4·NCT03857646·66 enrolled
Effects of Lipid Emulsions on Coagulation
Completed·—·N/A·NCT07470385·6,259 enrolled
Parenteral Lipid Emulsions and the Liver Function
Completed·SStanley Dudrick's Memorial Hospital·Phase 4·NCT03044639·64 enrolled
Lipid Emulsions and Liver Function - Results After 5 Years.
Completed·SStanley Dudrick's Memorial Hospital·Phase 4·NCT04347902·65 enrolled
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)
Completed·BBaxter Healthcare Corporation·Phase 4·NCT04555044·101 enrolled
Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.
Completed·—·Phase 4·NCT02924454·10 enrolled
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
Completed·EEmory University·Phase 2/3·NCT00672854·100 enrolled
Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers
Completed·EEmory University·Phase 2/3·NCT02185729·12 enrolled
Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic
Terminated·—·N/A·NCT00278928·82 enrolled
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion
Terminated·BBaxter Healthcare Corporation·Phase 4·NCT02476994·1 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)